For Moderate AS Patients, Baseline Factors Can Help ID Who's Most at Risk

Cleveland Clinic data, amid ongoing RCTs, suggest ways to target those with moderate AS most likely to benefit from earlier AVR.

Related Keywords

,Rishi Puri ,Cleveland Clinic ,